Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
Explore more US and African stocks, read the latest market news, or compare African stock exchanges on Wallflake.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. operates in the Healthcare sector and trades on the NASDAQ under the ticker AMGN.
Amgen Inc. is listed on the NASDAQ, where it trades under the ticker symbol AMGN. It is classified in the Healthcare sector.
AMGN last traded at USD 436.78 on 4 September 2026, down 1.65% on the session. Live prices for Amgen Inc. update through the trading day on Wallflake.
Amgen Inc. has a market capitalisation of approximately USD 236.14B, based on its closing price on 4 September 2026.
Over the past 52 weeks AMGN has traded between a low of USD 269.77 and a high of USD 447.03.
Yes. Amgen Inc. pays a dividend, with a trailing yield of 2.28%. Its payout ratio is approximately 60.87%.
AMGN has a price-to-earnings (P/E) ratio of 30.77 and earnings per share (EPS) of USD 14.23. These figures are reported metrics, not a valuation opinion — Wallflake does not issue buy, sell or hold recommendations.
AMGN shares are bought and sold through a broker licensed to trade on the NASDAQ. You open an account with a licensed broker, fund it, and place an order quoting the ticker AMGN. Wallflake is a market-data and research platform, not a broker, and does not execute trades or give investment advice. See our NASDAQ guide for how the market works. Read the guide
Figures are drawn from Wallflake's market data and are provided for information only. Nothing here is investment advice or a recommendation to buy or sell any security.